Diamedica Therapeutics (DMAC) Market Summary
- Current price: USD 8.72 per share on major exchanges.
- Price movement (last 24 h): +1.04 % to USD 8.72.
- Trading volume (last 24 h): USD 959.2 k.
- Shares outstanding: 53.9 million.
- Market capitalization: USD 470.2 million.
- Month‑to‑date performance: +11.37 % since the end of the previous month.
- 200‑day simple moving average: USD 7.09.
- 52‑week high: USD 10.42 (12 Oct 2025).
- 52‑week low: USD 5.24 (11 Jun 2026).
24‑Hour Performance of Peer Stocks
| Ticker | 24‑h change | Current price (USD) | Market cap (USD mn) | P/E ratio |
|---|---|---|---|---|
| PROK | -1.4 % | 1.41 | 562.8 | – |
| BSVN | -0.43 % | 58.55 | 557.7 | 13.68 |
| XMAX | -1.03 % | 8.66 | 558.8 | 11.87 |
| OLMA | -8.69 % | 6.41 | 560.9 | – |
| MYGN | +1.04 % | 5.82 | 556.7 | – |
Company Overview
DiaMedica Therapeutics Inc. is a clinical‑stage biopharmaceutical company focused on developing treatments for acute ischemic strokes and diabetic kidney disease. The company operates in the United States and Canada and is listed on the Nasdaq stock exchange. Its services and research activities are available through its website, www.diamedica.com .
